Pexelizumab and survival in cardiac surgery

A recent international consensus conference on the reduction in mortality in cardiac anesthesia and intensive care included pexelizumab, a recombinant monoclonal antibody to the component 5 of the complement system, among the ancillary (i.e. non-surgical) drugs/techniques/strategies that might influ...

Descripción completa

Detalles Bibliográficos
Autores principales: Testa, L, Meco, M, Cirri, S, Bedogni, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDIMES Edizioni Internazionali Srl 2011
Materias:
Article-Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484601/
https://www.ncbi.nlm.nih.gov/pubmed/23439772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484601/
https://www.ncbi.nlm.nih.gov/pubmed/23439772

Ejemplares similares